Michael Hintze is the founder of multi-strategy asset management firm CQS Cayman. In 2016, Hintze's CQS Directional Opportunities fund posted a stunning 30% return.
Keep Reading →
December 30 - Hedge Funds, News
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Keep Reading →
November 26 - Hedge Funds, News
After opening rather calmly on the news that Donald Trump is now the President-elect, the markets are down slightly as investors remain cautious on the political changes ahead...
Keep Reading →
November 9 - Market Movers, News
Our data culled from the 659 funds in our database which filed 13Fs for the June quarter, and whose portfolios contained at least 5 long positions in companies valued at $1 billion...
Keep Reading →
November 9 - Hedge Funds, News
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments.
Keep Reading →
November 4 - Hedge Fund Analysis, Hedge Funds, News
The mainstream media likes taking shots at hedge funds because they are easy targets.
Keep Reading →
November 3 - Hedge Fund Analysis, Hedge Funds, Market Movers, News
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)'s lung cancer drug brigatinib has been accepted for review by the FDA.
Keep Reading →
November 2 - News, Stock Analysis
Although the broader markets are still down/flat due in large part to Apple Inc.
Keep Reading →
October 26 - Market Movers, News
Although the broader markets are in the green today as a wave of M&A activity and a number of solid earnings reports have improved market sentiment, several stocks are not on ...
Keep Reading →
October 24 - Market Movers, News
While the second trading week of the fourth quarter is officially over, several major stocks are trending over the weekend, including Twitter Inc (NYSE:TWTR), salesforce.com, ...
Keep Reading →
October 15 - News, Tech
The markets are relatively quiet as the latest data shows that durable goods orders in the United States were relatively flat month-over-month in August.
Keep Reading →
September 28 - Market Movers, News
Crude futures are in the red today as sentiment around the commodity cools off.
Keep Reading →
July 28 - Market Movers, News
Crude futures are well in the green this morning as the worry over a potential 'Brexit' diminishes.
Keep Reading →
June 17 - Market Movers, News
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has said that it will file a new drug application (NDA) for its pipeline candidate brigatinib in 3Q2016.
Keep Reading →
June 8 - News, Stock Analysis
Last week’s dollar volume of all insider purchases almost doubled week-over-week, whereas the volume of insider selling decreased quite meaningfully relative to the volume of...
Keep Reading →
May 16 - Commodities, Insider Trading, News
When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare.
Keep Reading →
March 24 - Hedge Funds, News
Fresh data shows that 2015 was the year with the highest number of hedge fund closures since the financial crisis, as increased volatility in equity markets significantly impacted...
Keep Reading →
March 21 - Hedge Funds, News
Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary of the sector being overvalued...
Keep Reading →
December 20 - Hedge Funds, News
This week's roller coaster is coming to and end with a bang, as U.S. stocks are deep in the red territory and the Dow is down by triple digits.
Keep Reading →
December 18 - Market Movers, News, Tech
Is Ariad Pharmaceuticals, Inc.
Keep Reading →
December 1 - Hedge Funds, News
Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average...
Keep Reading →
September 16 - Hedge Funds, News
Less than a week after reports that Baxalta Inc (NYSE:BXLT) wanted to acquire Ariad Pharmaceuticals, Inc.
Keep Reading →
September 3 - Hedge Funds, News
JS Capital Management is a New York-based hedge fund founded and led by Jonathan Soros.
Keep Reading →
June 17 - Hedge Funds, News
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr.
Keep Reading →
April 15 - Hedge Funds, News
Alex Denner’s Sarissa Capital Management recently disclosed its stock picks for the fourth quarter of 2014 in a 13F Form filed with the U.S.
Keep Reading →
February 21 - Hedge Funds, News
As a new filing with the Securities and Exchange Commission showed, Sarissa Capital Management, a fund led by Alex Denner, has picked up its position in Ariad Pharmaceuticals...
Keep Reading →
August 25 - Hedge Funds, News
Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings.
Keep Reading →
February 14 - Hedge Funds, News
Hedge funds held up better than global stocks last month, falling an average of 0.1 percent as equities slumped amid a selloff in emerging-market currencies and signs of weakness...
Keep Reading →
February 7 - Hedge Funds
According to a new filing with the SEC, Sarissa Capital Management now holds around 11.5 million shares of Ariad Pharmaceuticals, Inc.
Keep Reading →
October 29 - Hedge Funds, News
Stephen DuBois, Ariad Pharmaceuticals: In a new filing just reported to the SEC, Stephen DuBois's Camber Capital disclosed a new 5.4% stake in Ariad Pharmaceuticals, Inc. (...
Keep Reading →
October 23 - Hedge Funds, News
After a truly remarkable 20-month 650% gain, shares of Santarus, Inc. (NASDAQ:SNTS) have fallen by more than 20% since its all-time high in early August.
Keep Reading →
September 13 - News
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen.
Keep Reading →
September 12 - News
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.
Keep Reading →
September 10 - News
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
Keep Reading →
August 30 - News
Today, let's look at investing giant Daniel Loeb, founder of the Third Point LLC hedge fund.
Keep Reading →
August 30 - Hedge Funds, News
Santarus, Inc. (NASDAQ:SNTS) has risen over 300% in the past year partly based on sales optimism for ulcerative colitis drug Uceris, which launched in the first quarter.
Keep Reading →
August 28 - News
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age.
Keep Reading →
August 28 - News
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings.
Keep Reading →
August 27 - News
In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.
Keep Reading →
August 25 - News
Ariad Pharmaceuticals, Inc.
Keep Reading →
August 8 - News
Santarus, Inc. (NASDAQ:SNTS) has traded higher by 250% over the last year, and much of those gains have been created after the company’s last two quarterly reports.
Keep Reading →
July 24 - News
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is trading higher after rejecting a takeover bid.
Keep Reading →
July 9 - News
There are many biotech stocks that target cancer, but what is good about Celldex Therapeutics, Inc.
Keep Reading →
July 3 - News
While the analysis of peak sales and potential patient populations may be appealing to most, it costs a great deal of money to launch a new product with success.
Keep Reading →
July 1 - News
Investing in biotech companies isn't without its challenges, but it doesn't have to be a shot in the dark, either.
Keep Reading →
June 27 - News
There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-growth as sales increase ...
Keep Reading →
June 27 - News
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view.
Keep Reading →
June 3 - News
The American Society of Clinical Oncology annual meeting kicks off today.
Keep Reading →
June 3 - News
To the average investor, there are a multitude of indicators market participants can use to watch publicly traded companies.
Keep Reading →
May 30 - News